Combined effects of genetic polymorphisms in six selected genes on lung cancer susceptibility

Lung Cancer

Volumn 57, Issue 2, 2007, Pages 135-142

  Yang, Mihi ^a   Choi, Yunhee ^b   Hwangbo, Bin ^c   Lee, Jin Soo ^c  

^a Sookmyung Women's University   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c National Cancer Center   (South Korea)

Author keywords

CYP1A1; Genetic polymorphism; GSTM1; GSTP1; GSTT1; Lung cancer; MPO; NQO1

Indexed keywords

ADULT; AGED; ALLELE; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CONFIDENCE INTERVAL; CONTROLLED STUDY; CYP1A1 GENE; FEMALE; GENE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GSTM1 GENE; GSTP1 GENE; GSTT1 GENE; HOMOZYGOTE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MPO GENE; NQO1 GENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SOUTH KOREA;

AGED; CASE-CONTROL STUDIES; CYTOCHROME P-450 CYP1A1; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GLUTATHIONE TRANSFERASE; HUMANS; KOREA; LUNG NEOPLASMS; MALE; MIDDLE AGED; NAD(P)H DEHYDROGENASE (QUINONE); PEROXIDASE; POLYMORPHISM, GENETIC; QUESTIONNAIRES; RISK FACTORS; SMOKING;

EID: 34447251538     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2007.03.005     Document Type: Article

References (33)

1. Cancer Registration & Biostatistics Branch NCC. Cancer statistics in Korea, 2000. http://wwwnccrekr/files/statistics/Cancer%20Statistics%20in%20KOREAdoc
2. International Agency for Research on Cancer. IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans: Tobacco Smoking Lyon (1986), IARC
3. Bilello K.S., Murin S., and Matthay R.A. Epidemiology, etiology, and prevention of lung cancer. Clin Chest Med 23 (2002) 1-25
4. Wiencke J.K., Thurston S.W., Kelsey K.T., Varkonyi A., Wain J.C., Mark E.J., et al. Early age at smoking initiation and tobacco carcinogen DNA damage in the lung. J Natl Cancer Inst 91 (1999) 614-619
5. In: Vines P., Malats N., Lang M., d'Errico A., Caporaso N., Cuzick J., and Boffetta P. (Eds). Metabolic polymorphisms and susceptibility to cancer (1999), IARC, Lyon
6. Stabile L.P., and Siegfried J.M. Sex and sex differences in lung cancer. J Gend Specif Med 6 (2003) 37-48
7. Chen H., Lum A., Seifried A., Wilkens L.R., and Le Marchand L. Association of the NAD(P) H:quinone oxidoreductase 609C->T polymorphism with a decreased lung cancer risk. Cancer Res 59 (1999) 3045-3048
8. Cosma G., Crofts F., Taioli E., Toniolo P., and Garte S. Relationship between genotype and function of the human CYP1A1 gene. J Toxicol Environ Health 40 (1993) 309-316
9. Le Marchand L., Guo C., Benhamou S., Bouchardy C., Cascorbi I., Clapper M.L., et al. Pooled analysis of the CYP1A1 exon 7 polymorphism and lung cancer (United States). Cancer Causes Control 14 (2003) 339-346
10. Dally H., Gassner K., Jager B., Schmezer P., Spiegelhalder B., Edler L., et al. Myeloperoxidase (MPO) genotype and lung cancer histologic types: the MPO -463 A allele is associated with reduced risk for small cell lung cancer in smokers. Int J Cancer 102 (2002) 530-535
11. Coles B., Yang M., Lang N.P., and Kadlubar F.F. Expression of hGSTP1 alleles in human lung and catalytic activity of the native protein variants towards 1-chloro-2,4-dinitrobenzene, 4-vinylpyridine and (+)-anti benzo[a]pyrene-7,8-diol-9,10-oxide. Cancer Lett 156 (2000) 167-175
12. Yang M., Coles B.F., Delongchamp R., Lang N.P., and Kadlubar F.F. Effects of the ADH3, CYP2E1, and GSTP1 genetic polymorphisms on their expressions in Caucasian lung tissue. Lung Cancer 38 (2002) 15-21
13. Watson M.A., Stewart R.K., Smith G.B., Massey T.E., and Bell D.A. Human glutathione-S-transferase P1 polymorphisms: relationship to lung tissue enzyme activity and population frequency distribution. Carcinogenesis 19 (1998) 275-280
14. Sundberg K., Johansson A.S., Stenberg G., Widersten M., Seidel A., Mannervik B., et al. Differences in the catalytic efficiencies of allelic variants of glutathione transferase P1-1 towards carcinogenic diol epoxides of polycyclic aromatic hydrocarbons. Carcinogenesis 19 (1998) 433-436
15. Perera F.P., Mooney L.A., Stampfer M., Phillips D.H., Bell D.A., Rundle A., et al. Associations between carcinogen-DNA damage, glutathione-S-transferase genotypes, and risk of lung cancer in the prospective Physicians' Health Cohort Study. Carcinogenesis 23 (2002) 1641-1646
16. Sorensen M., Autrup H., Tjonneland A., Overvad K., and Raaschou-Nielsen O. Glutathione-S-transferase T1 null-genotype is associated with an increased risk of lung cancer. Int J Cancer 110 (2004) 219-224
17. Oyama T., Mitsudomi T., Kawamoto T., Ogami A., Osaki T., Kodama Y., et al. Detection of CYP1A1 gene polymorphism using designed RFLP and distributions of CYP1A1 genotypes in Japanese. Int Arch Occup Environ Health 67 (1995) 253-256
18. Cancer Genome Anatomy Project SNP500Cancer Database. http://snp500cancer.nci.nih.gov/taqman_assays.cfm?snp_id=MPO-02
19. Gao C.M., Takezaki T., Wu J.Z., Li Z.Y., Liu Y.T., Li S.P., et al. Glutathione-S-transferases M1 (GSTM1) and GSTT1 genotype, smoking, consumption of alcohol and tea and risk of esophageal and stomach cancers: a case-control study of a high-incidence area in Jiangsu Province. China Cancer Lett 188 (2002) 95-102
20. Kelada S.N., Stapleton P.L., Farin F.M., Bammler T.K., Eaton D.L., Smith-Weller T., et al. Glutathione-S-transferase M1, T1, and P1 polymorphisms and Parkinson's disease. Neuroscience Lett 337 (2003) 5-8
21. Hamajima N., Saito T., Matsuo K., Suzuki T., Nakamura T., Matsuura A., et al. Genotype frequencies of 50 polymorphisms for 241 Japanese non-cancer patients. J Epidemiol 12 (2002) 229-236
22. Hamajima N., Takezaki T., and Tajima K. Allele frequencies of 25 polymorphisms pertaining to cancer risk for Japanese, Koreans and Chinese. Asian Pac J Cancer Prev 3 (2002) 197-206
23. Miller D.P., Neuberg D., de Vivo I., Wain J.C., Lynch T.J., Su L., et al. Smoking and the risk of lung cancer: susceptibility with GSTP1 polymorphisms. Epidemiology 14 (2003) 545-551
24. Chan E.C., Lam S.Y., Fu K.H., and Kwong Y.L. Polymorphisms of the GSTM1, GSTP1, MPO, XRCC1, and NQO1 genes in Chinese patients with non-small cell lung cancers: relationship with aberrant promoter methylation of the CDKN2A and RARB genes. Cancer Genet Cytogenet 162 (2005) 10-20
25. Ye Z., Song H., Higgins J.P., Pharoah P., and Danesh J. Five glutathione-S-transferase gene variants in 23,452 cases of lung cancer and 30,397 controls: meta-analysis of 130 studies. PLoS Med 3 (2006) e91
26. Nazar-Stewart V., Motulsky A.G., Eaton D.L., White E., Hornung S.K., Leng Z.T., et al. The glutathione-S-transferase mu polymorphism as a marker for susceptibility to lung carcinoma. Cancer Res 53 10 Sup (1993) 2313-2318
27. Van Schooten F.J., Boots A.W., Knaapen A.M., Godschalk R.W., Maas L.M., Borm P.J., et al. Myeloperoxidase (MPO) -463G->A reduces MPO activity and DNA adduct levels in bronchoalveolar lavages of smokers. Cancer Epidemiol Biomarkers Prev 13 (2004) 828-833
28. Feyler A., Voho A., Bouchardy C., Kuokkanen K., Dayer P., Hirvonen A., et al. Point: myeloperoxidase -463G-> a polymorphism and lung cancer risk. Cancer Epidemiol Biomarkers Prev 11 (2002) 1550-1554
29. Xu L.L., Liu G., Miller D.P., Zhou W., Lynch T.J., Wain J.C., et al. Counterpoint: the myeloperoxidase -463G-> a polymorphism does not decrease lung cancer susceptibility in Caucasians. Cancer Epidemiol Biomarkers Prev 11 (2002) 1555-1559
30. Kawajiri K., Nakachi K., Imai K., Yoshii A., Shinoda N., and Watanabe J. Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P450IA1 gene. FEBS Lett 263 (1990) 131-133
31. Larsen J.E., Colosimo M.L., Yang I.A., Bowman R., Zimmerman P.V., and Fong K.M. CYP1A1 Ile462Val and MPO G-463A interact to increase risk of adenocarcinoma but not squamous cell carcinoma of the lung. Carcinogenesis 27 (2006) 525-532
32. Kiyohara C., Yoshimasu K., Takayama K., and Nakanishi Y. NQO1, MPO, and the risk of lung cancer: a HuGE review. Genet Med 7 (2005) 463-478
33. Chao C., Zhang Z.F., Berthiller J., Boffetta P., and Hashibe M. NAD(P)H:quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and the risk of lung, bladder, and colorectal cancers: a meta-analysis. Cancer Epidemiol Biomarkers Prev 15 (2006) 979-987